Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
US OptionsDetailed Quotes
PFE250502P18500
- 0.01
- 0.000.00%
15min DelayTrading Apr 30 09:30 ET
0.01High0.01Low
0.01Open0.01Pre Close1 Volume767 Open Interest18.50Strike Price1.00Turnover157.47%IV23.89%PremiumMay 2, 2025Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type-0.0099Delta0.0092Gamma2429.50Leverage Ratio-0.0096Theta0.0000Rho-24.00Eff Leverage0.0005Vega
Pfizer Newsroom
Pfizer Analyst Ratings
BofA Securities Adjusts Price Target on Pfizer to $27 From $26, Maintains Neutral Rating
UBS Adjusts Price Target on Pfizer to $25 From $24, Maintains Neutral Rating
A Quick Look at Today's Ratings for Pfizer(PFE.US), With a Forecast Between $24 to $32
Pfizer Positioned for Growth: Buy Rating Affirmed Due to Operational Efficiency, Strategic Capital Allocation, and Undervaluation
Citigroup Adjusts Price Target on Pfizer to $25 From $23, Maintains Neutral Rating
Goldman Sachs Ups Price Target on Pfizer to $27 From $25, Maintains Neutral Rating
Morgan Stanley Lifts Price Target on Pfizer to $32 From $31, Keeps Equalweight Rating
Pfizer's Mixed Q1 Results and Uncertain Long-Term Prospects Justify Hold Rating
Jefferies Reaffirms Their Buy Rating on Pfizer (PFE)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Pfizer (PFE) and Nautilus Biotechnolgy (NAUT)
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Phathom Pharmaceuticals (PHAT) and Exact Sciences (EXAS)
Research Alert: Solid Q1 Eps Beat, While Revenue Slightly Disappoints; 2025 Guidance Maintained
Pfizer's Financial Outlook: Hold Rating Amidst Short-Term Challenges and Long-Term Potential
Wells Fargo Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $28
HSBC Maintains Pfizer(PFE.US) With Buy Rating, Cuts Target Price to $27
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (PFE), Vertex Pharmaceuticals (VRTX) and Erasca (ERAS)
Analysts Sound Caution on Pfizer Stock (PFE) Ahead of Q1 Earnings
Pfizer's Stock Outlook: Analysts Weigh In on Future Prospects
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Pfizer (PFE) and Madrigal Pharmaceuticals (MDGL)
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now